BioProcess International
23 September 202426 September 2024
Boston, USAHynes Convention Center
An event exploring next-generation platforms and processes to deliver transformative therapies with precision, quality and scalability.
The 2024 agenda includes 9 conference tracks covering novel science across all phases of bioprocessing for biologics, cell & gene therapies. Attendees can stay informed on today's important bioprocessing topics across sustainability, tech transfer, CMC analytics, CDMO partnerships and more by attending pre-conference workshops led by top industry scientists in an interactive classroom setting.
The exhibit hall features 250+ CDMOs, CROs and suppliers who will showcase the industry's latest technologies designed to accelerate your novel biotherapeutic towards commercial success.
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze